Apex Labs Granted Approval for North America’s First Take Home Psilocybin Clinical Trial Post published:November 1, 2022 Post category:Press Release
Reunion Neuroscience to Present at Upcoming November Conferences Post published:November 1, 2022 Post category:Press Release
Numinus to Participate in Wonderland: Miami on November 3-5, 2022 Post published:October 31, 2022 Post category:Press Release
Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028 Post published:October 31, 2022 Post category:Press Release
ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD’S FIRST IN-CLINIC APPLICATION OF VIRTUAL REALITY MODULATED PSYCHEDELIC-AUGMENTED PSYCHOTHERAPY Post published:October 31, 2022 Post category:Press Release
Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness Post published:October 28, 2022 Post category:Press Release
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022 Post published:October 28, 2022 Post category:Press Release
HAVN Life Announces Retail Listing With Loblaws Company Ltd. Post published:October 28, 2022 Post category:Press Release
Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences Post published:October 28, 2022 Post category:Press Release
MINDCURE Announces Financial Results for the First Quarter of Fiscal 2023 USA – English USA – English Post published:October 27, 2022 Post category:Press Release